Authors
Loading...
Clinical study reveals BRAF V600E mutation predicts relapse in pediatric Langerhans cell histiocytosis, highlighting targeted therapy for multisystem disease.
Özer et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: